Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A novel approach inducing transplant tolerance by activated invariant natural killer T cells with costimulatory blockade.

A novel approach inducing transplant tolerance by activated invariant natural killer T cells with costimulatory blockade. Am J Transplant. 2014 Mar; 14(3):554-67.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.